Completed PHASE1 INTERVENTIONAL 2-arm NCT00223691

Treatment of Orthostatic Hypotension in Autonomic Failure

Evaluation and Treatment of Autonomic Failure.

Sponsor: Vanderbilt University

Conditions Autonomic Failure Orthostatic Hypotension

Updated 6 times since 2017 Last updated: Jan 16, 2017 Started: Mar 31, 2002 Primary completion: Jan 31, 2017 Completion: Jan 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00223691, this PHASE1 trial focuses on Autonomic Failure and Orthostatic Hypotension and remains completed. Sponsored by Vanderbilt University, it has been updated 6 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

Status: Recruiting → Completed · Phase: PHASE3 → PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Mar 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States